Ziextenzo
Payments companies reported to CMS as associated with Ziextenzo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ziextenzo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ziextenzo
These are the largest totals companies reported as associated with Ziextenzo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kashyap Patel | Rock Hill, SC | Hematology & Oncology | $29.26 |
| Asutosh Gor | Rock Hill, SC | Hematology & Oncology | $29.26 |
| Lakisha Mcdonald | Rock Hill, SC | Gerontology (Nurse Practitioner) | $29.26 |
| Sashi Naidu | Rock Hill, SC | Hematology & Oncology | $29.26 |
| Viral Rabara | Rock Hill, SC | Hematology & Oncology | $29.26 |
| Alida Espinoza | Hagerstown, MD | Hematology & Oncology | $22.34 |
| Kashif Firozvi | Silver Spring, MD | Hematology & Oncology | $22.34 |
| Hee Kim | Eau Claire, WI | Internal Medicine | $22.34 |
| Cynthia Plate | Takoma Park, MD | Surgery | $22.34 |
Prescribed Ziextenzo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.